AFT Pharmaceuticals (ASX:AFP): Double digit revenue growth in 1H27
Yesterday morning (6 October 2026), AFT Pharmaceuticals (ASX:AFT) released a financial update confirming to investors that its guidance for FY27 (the 12 months to the end of March 2027) was on track based on a strong performance in the first half of the year. AFT reiterates NZ$28-32m operating profit and $300m in annual revenue guidance […]